Skip to content
NYSE · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · LARGE CAP

Colgate Palmolive Co. CL

19 fiscal years on record · USD · FY2025 reported · SEC filings only
$20.4B
▲ 1.4% YoY
$2.1B
▼ 26.2% YoY
$3.6B
▲ 2.5% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

Colgate-Palmolive operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. Its products are marketed in over 200 countries and territories throughout the world. As of December 31, 2025, it had approximately 33,600 employees based in over 100 countries. It sells toothpaste under brands including Colgate, Darlie, elmex, hello, meridol, Sorriso and Tom's of Maine, toothbrushes under brands including Colgate, Darlie, elmex and meridol, and mouthwashes under brands including Colgate, elmex and meridol. Its Personal Care products include Irish Spring, Palmolive and Protex bar soaps, Irish Spring, Palmolive, Sanex and Softsoap shower gels, Lady Speed Stick, Sanex, Speed Stick and Tom's of Maine deodorants and antiperspirants, EltaMD, Filorga and PCA SKIN skin health products, and Palmolive shampoos and conditioners. It manufactures and markets Home Care products including Ajax, Axion and Palmolive dishwashing liquids, Ajax, Fabuloso and Murphy household cleaners, and Suavitel, Soupline, Fluffy and Cuddly fabric conditioners. Colgate-Palmolive was founded in 1806 and incorporated under the laws of the State of Delaware in 1923.

Written from the business description in COLGATE-PALMOLIVE COMPANY's annual report to the U.S. Securities and Exchange Commission, filed 23 February 2026. Every sentence was checked against that document before publication.

Growth

USD 20.4B
Revenue, FY2025 · full 19-year series below
Revenue $B Net income $B
FY2025 · Revenue 20.4 · Net income 2.1
10B20B
2007201020132016201920222025
Compound annual growth
+4.3%
+4.4%
+2.4%
+1.8%
+6.1%
−4.6%
+4.4%
−0.2%
+7.3%
−3.5%
+5.6%
+3.8%
+3.5%
+7.6%
+13.0%
−1.2%
−3.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +4.4% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

11 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 16.2% · Net 11.1%
10%20%
200720162025
ROE
FY2024 · ROE 703.8%
200%400%600%
200720162025
Three returns, three denominators.
Return on equityNot applicable: equity is too small for this ratio to describe the business — the result would reflect the denominator, not performance.

Return on equity has no reading this year — return on capital employed, just below, still does: 33%.

Cash & shareholders

USD 1.1B
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 3.6
2B3B
200720162025
Net buybacks $B Dividends $B
FY2025 · Dividends · · Net buybacks 1.1
1B2B
2007201020132016201920222025

USD 1.1B in buybacks — 52% of the year's profit went back to shareholders.

Total assetsUSD 16.3B
EquityUSD 54.0M
CashUSD 1.3B
Gross debtUSD 8.0B
Net debtUSD 6.7B
Current ratio0.83×

Net debt stands at 12404% of equity.

The 19-year record

19 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
CL, 19-year financial record
Metric 2025202420232022202120202019201820172016201520142013201220112010200920082007
Revenue $B20.420.119.518.017.416.515.715.515.515.216.017.317.417.116.715.615.315.313.8
Operating income $B3.34.34.02.93.33.93.63.73.74.02.83.63.63.93.83.53.63.12.7
EBITDA $B3.94.94.63.43.94.44.14.24.24.43.24.04.04.34.33.94.03.43.1
Income tax $B0.80.90.90.70.70.80.80.91.31.21.21.21.21.21.21.11.11.00.8
Net income $B2.12.92.31.82.22.72.42.42.02.41.42.22.22.52.42.22.32.01.7
Free cash flow $B3.63.53.01.92.83.32.82.62.52.52.32.52.52.62.42.72.71.61.7
EPS, diluted $2.633.512.772.132.553.142.752.752.282.721.522.362.382.572.474.314.373.663.20
Dividend / sh $2.082.481.911.861.791.751.711.661.59◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————————————
ROE %—703.8455.4353.5320.4626.7—————126.499.7108.396.376.190.9101.8◌
Shares out B0.800.810.820.830.840.850.850.860.870.880.890.910.920.470.480.490.490.500.51

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

Compare

This company against its peers

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 92 reconciliationsAUDITED

Reconciled in 19 of the 19 fiscal years we could check. Two checks were skipped: the balance sheet is not tagged before 2008. One check was skipped: the share count is not tagged before 2008.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPerfumes, Cosmetics & Other Toilet Preparations
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2007

Share this section

Download image